# HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

> **NCT00410254** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 38 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HCV-796
- **DRUG:** midazolam

## Key facts

- **NCT ID:** NCT00410254
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410254, "HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00410254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*